Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...
Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...
With the holidays past and the new year arrived, we look ahead — to losing weight. For some that resolve theoretically ...
Ozempic and similar drugs are advertised all over the place, from television ads, public transit, audio streaming platforms ...
Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.